Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update

<p>Recent Data Publications Highlight the Benefits of Oxylanthanum Carbonate (OLC) to Improve Medication Adherence and Quality of Life for Patients with Chronic Kidney Disease Feedback from FDA Expected in Fall 2023 for OLC Program UNI-494 Phase 1 Trial Progressing as Planned with IND Application Expected in 2024 LOS ALTOS, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/unicycive-announces-second-quarter-2023-financial-results-and-provides-business-update/">Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>